Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interkeukin-2

C. F. LeMaistre*, Mansoor N. Saleh, Timothy M. Kuzel, Francine Foss, Leonidas C. Platanias, Gary Schwartz, Mark Ratain, Alain Rook, Cesar O. Freytes, Fiona Craig, James Reuben, Jean C. Nichols

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

197 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interkeukin-2'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Immunology and Microbiology